| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |